Abstract
The in vitro activity of BL-S640, a 7-(2-aryl-2-aminoacetamido)-3-(heterocyclic-thiomethyl) cephalosporin, was evaluated against 338 clinical isolates of Enterobacteriaceae in comparison with ampicillin, cephalothin, cefazolin, and cephalexin. Against Escherichia coli, BL-S640 was as active as cefazolin and more active than ampicillin, cephalothin, and cephalexin. BL-S640 was as effective as the other cephalosporins tested and far more active than ampicillin against Klebsiella and was more active than cephalexin against Proteus mirabilis and the indole-positive Proteus. The majority of Enterobacter, Serratia, and Citrobacter were resistant to ampicillin and all the cephalosporins tested. With rare exceptions, the zone of inhibition by the BL-S640 30-μg disk was either larger or the same as the zone obtained by the cephalothin 30-μg disk in the Kirby-Bauer disk susceptibility test.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Griffith R. S., Black H. R. Cephalexin. Med Clin North Am. 1970 Sep;54(5):1229–1244. [PubMed] [Google Scholar]
- Scholand J. F., Hodges G. R., Fass R. J., Saslaw S. Clinical evaluation of cephradine, a new oral cephalosporin. Am J Med Sci. 1974 Feb;267(2):111–116. doi: 10.1097/00000441-197402000-00005. [DOI] [PubMed] [Google Scholar]
- Seneca H. Drug susceptibility-resistance pattern of gram-negative uropathogens to seven cephalosporins. Am J Med Sci. 1973 Nov;266(5):381–385. doi: 10.1097/00000441-197311000-00005. [DOI] [PubMed] [Google Scholar]